Table 5 |
||||
| Summary of 3 on-going studies | ||||
| On-going studies | Location | Inclusion criteria | Treatment used in study groups, n = | Outcomes, Estimated date of completion |
| Cabana 201057 | USA | >37 weeks gestation, birth weight >2500 g and < 4500 g, 14±3 days of age on enrollment, singleton birth, non- breastfed, not received solid foods. | 1) Study group 1: Test starter infant formula | Primary: Weight gain (g/day) at 14 to 112 days of life (4 months) |
| 2) Study group 2: Test starter infant formula with synbiotics | ||||
| 3) Control /placebo group: Standard formula | Secondary: Tolerance, morbidity, protein status, metabolic markers December 2011 | |||
| Zegerman 200958 | Israel | 37th and 42 week gestation, birth weight > 2500 g, recruitment age: 0–28 days, non-breastfed | 1) Study group 1: Dietary Supplement: probiotic microorganism and/or prebiotic | Primary: weight, length, head circumference |
| 2) Dietary Supplement: probiotic microorganism and/or prebiotic | Secondary: Microbiology August 2012 | |||
| 3) Dietary Supplement: probiotic microorganism and /or prebiotic | ||||
| Ye 201059 | Singapore | > 37 weeks to < 42 weeks gestation, singleton birth. Age at enrolment < 14 days old | 1) Study group 1: Standard infant formula with prebiotics | Primary: Mean Weight gain |
| 2) Study group: Infant formula with synbiotics | Secondary: Digestive tolerance December 2011 | |||
Mugambi et al. Nutrition Journal 2012 11:81 doi:10.1186/1475-2891-11-81
